The Biomarkers market is anticipated to reach USD$ 46.5 billion by 2020, expanding at a CAGR of 13.58% between 2016 and 2020. growing demand for companion diagnostics and the rising adoption of personalized medicine are the key factors propelling the growth of the biomarkers market. A biological marker, better known as a “biomarker”, is a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention.

North America held the largest regional share of around 39% in 2015. The well-established R&D infrastructure and the high level of disposable income are the factors contributing towards the large market share.

Asia Pacific is anticipated to be the fastest growing biomarker market owing to the factors, such as the developing economic conditions, a large base of the target population, and a favorable regulatory scenario for clinical trials.

The diagnostic segment is estimated to witness a lucrative growth over the forecast period owing to the growing awareness about routine healthcare checkups and the rising prevalence of various diseases

In 2015, the oncology segment dominated with a revenue generated over USD 9.2 billion owing to the introduction of companion diagnostic tests for oncology drugs and the growing burden of cancer across the globe

The cardiovascular segment is expected to be the fastest growing segment with a CAGR of over 14.0%. The growing adoption of sedentary lifestyles and the rise in the obese population base leading to cardiovascular diseases are estimated to provide this market with a potential growth platform.

Read Full Report: http://www.gosreports.com/global-biomarkers-industry-2015-market-research-report/

Joanna | Executive – International Business and partner Relations
E-mail: [email protected] | Tel: 1-510-400-8520
Web: www.gosreports.com